Jessica Grossman

Jessica Grossman, M.D., joined IgGenix in November 2020 as the CEO, bringing more than 20 years of healthcare leadership experience to the company. Most recently, she served as CEO of Medicines360, a global nonprofit drug company with a mission to expand access to essential medicines for all women. As CEO, she increased revenue by 200% and raised $20 million in non-dilutive capital for market expansion and product development while realigning the leadership team and Board. Previously, she served as founding President and CEO of Sense4Baby, Inc., raising a successful Series A venture round. Before Sense4Baby, she founded Gynesonics, and served as President, developing the strategic vision, building the company and successfully raising two rounds of venture capital financing. Dr. Grossman serves on the Board of Directors of Dare Biosciences. She holds 11 issued patents and has published several peer reviewed articles. She earned her M.D. degree at Thomas Jefferson University and her B.A.s in Biology and American Literature from Brandeis University.